COSMO BIO COMPANY, LIMITED【JP:3386】Cash flow
Market cap
¥7.9B
P/E ratio
17.2x
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 83 | 79 | 85 | 156 | 178 | 207 | 175 | 166 | 141 | 148 | 136 |
| Cash from operations | 297 | 129 | 573 | 89 | 908 | 549 | 803 | 648 | 284 | 736 | 241 |
| Capital expenditures | -53 | -49 | -129 | -479 | -51 | -141 | -36 | -31 | -55 | -67 | -216 |
| Cash from investing | -227 | -263 | 99 | -235 | -185 | -115 | 42 | -145 | -291 | -758 | -217 |
| Payments for dividends | -118 | -106 | -94 | -106 | -82 | -82 | -94 | -223 | -232 | -197 | -175 |
| Repurchases of common stock | - | - | - | - | - | - | - | -194 | - | - | -144 |
| Cash from financing | -122 | -151 | -107 | -109 | -85 | -85 | -97 | -420 | -236 | -201 | -479 |